cyclohexanol has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q; Liu, SN; Shen, ZF; Sun, SJ | 1 |
| Bennett, BL; Friedman, GC; Lim, AK; Ma, FY; Nikolic-Paterson, DJ; Ozols, E; Tesch, GH; Young, MJ | 1 |
2 other study(ies) available for cyclohexanol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
[Valibose, an alpha-glucosidase inhibitor, ameliorates the metabolic disorder of glucose and lipids and the nephropathy in streptozotocin-induced diabetic rats].
Topics: Acetylglucosaminidase; Animals; Blood Glucose; Blood Urea Nitrogen; Cholesterol; Creatinine; Cyclohexanols; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Fructosamine; Glycoside Hydrolase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Kidney; Male; Rats; Rats, Sprague-Dawley; Triglycerides; Weight Gain | 2013 |
Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats.
Topics: Albuminuria; Animals; Blood Pressure; Body Weight; Cyclohexanols; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Early Medical Intervention; Hypertension; Hypertrophy; Immunohistochemistry; Inhibitory Concentration 50; Male; MAP Kinase Kinase 4; Protein Kinase Inhibitors; Purines; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction | 2011 |